Total Knee Replacement
Conditions
Brief summary
This trial is a prospective, single center, unblinded, randomized, controlled study to assess the safety and efficacy of negative pressure wound therapy in preventing infections after TKA surgery . The study will enroll 316 patients that will undergo TKA. patients will be randomized to the treatment group and undergo the study intervention - (NPWT) The intervention will take place at the end of the surgery. The Patients that are randomized to the control group will receive standard treatment. Both groups will be assessed at two weeks and six weeks. period.
Interventions
DRUGstandard prophylactic therapy
administration of antibiotics before the first incision, keeping the surgery field sterile and performing several rinsing
Sponsors
Hadassah Medical Organization
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Ages: 18 to 80 * Males- not involved in active military duty. * Females-non child bearing potential, or females of child-bearing potential who have a negative pregnancy test (hCG urine) within 72 hours of informed consent.
Exclusion criteria
* Active systemic or local infection. * History of malignancy, radiotherapy, or chemotherapy for malignancy (except BCC of the skin) * Active autoimmune disease. * Any past or present immunosuppressive treatment. * Current treatment with chemotherapeutic agents * History of metabolic bone disease (primary or secondary). * Chronic renal insufficiency (defined by 50% increase of normal levels).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The primary endpoint of the study is to evaluate the proportion of infections at the treatment and control groups after six weeks | six weeks | The primary endpoint of the study is to evaluate the proportion of infections at the treatment and control groups after six weeks |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 1. To assess the proportion on infections at two weeks and 6 weeks of follow-up. | two weeks and six weeks | To assess the proportion on infections at two weeks and 6 weeks of follow-up. |
| The number of patients recommended to undergo further procedural intervention because of the infection. | 12 MONTHS | The number of patients recommended to undergo further procedural intervention because of the infection. |
Outcome results
None listed